{"DataElement":{"publicId":"7507232","version":"1","preferredName":"Gastrointestinal Stromal Tumor Other Gene Mutation Name","preferredDefinition":"The name of another gene associated with Gastrointestinal Stromal Tumor (GIST) not previously specified.","longName":"GIST_OTH_GENE_MUT_NM","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"7507231","version":"1","preferredName":"Gastrointestinal Stromal Tumor Other Gene Mutation","preferredDefinition":"A stromal tumor most commonly seen in the gastrointestinal tract. Rare cases of solitary masses in the omentum or the mesentery have also been reported (extragastrointestinal gastrointestinal stromal tumor).  It is a tumor that differentiates along the lines of interstitial cells of Cajal.  Most cases contain KIT- or PDGFRA-activating mutations. Until recently, surgery has been the only effective therapy for this tumor.  However, many patients still experience recurrence.  Conventional chemotherapy and radiation therapy have been of limited value.  A KIT tyrosine kinase inhibitor, imatinib mesylate (also known as STI-571 or Gleevec), is now effective in the treatment of relapsed and unresectable cases._Different than the one(s) previously specified or mentioned._The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.","longName":"2875746v1.0:7507229v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2875746","version":"1","preferredName":"Gastrointestinal Stromal Tumor","preferredDefinition":"GIST. A type of tumor that usually begins in cells in the wall of the gastrointestinal tract.  It can be benign or malignant.","longName":"C3868","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal Stromal Tumor","conceptCode":"C3868","definition":"A stromal tumor most commonly seen in the gastrointestinal tract. Rare cases of solitary masses in the omentum or the mesentery have also been reported (extragastrointestinal gastrointestinal stromal tumor).  It is a tumor that differentiates along the lines of interstitial cells of Cajal.  Most cases contain KIT- or PDGFRA-activating mutations. Until recently, surgery has been the only effective therapy for this tumor.  However, many patients still experience recurrence.  Conventional chemotherapy and radiation therapy have been of limited value.  A KIT tyrosine kinase inhibitor, imatinib mesylate (also known as STI-571 or Gleevec), is now effective in the treatment of relapsed and unresectable cases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69CC3F8C-54D3-DD89-E040-BB89AD4301CB","latestVersionIndicator":"Yes","beginDate":"2009-05-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-05-13","modifiedBy":"ONEDATA","dateModified":"2009-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7507229","version":"1","preferredName":"Other Gene Mutation","preferredDefinition":"Different than the one(s) previously specified or mentioned.:The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.","longName":"C17649:C18093","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gene Mutation","conceptCode":"C18093","definition":"The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B464A8B4-8D03-6AAB-E053-4EBD850AA390","latestVersionIndicator":"Yes","beginDate":"2020-11-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-18","modifiedBy":"ONEDATA","dateModified":"2020-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B464A8B4-8D14-6AAB-E053-4EBD850AA390","latestVersionIndicator":"Yes","beginDate":"2020-11-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-18","modifiedBy":"COOPERM","dateModified":"2020-11-18","changeDescription":"Created for NCI-INC0538595 20C0161 Exon and codon request. 11.17.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7507228","version":"1","preferredName":"Gene Mutation Name","preferredDefinition":"The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA._The words or language units by which a thing is known.","longName":"GENE_MUT_NM","context":"CCR","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2435027","version":"1","preferredName":"Gene","preferredDefinition":"A functional unit of heredity which occupies a specific position (locus) on a particular chromosome, is capable of reproducing itself exactly at each cell division, and directs the formation of a protein or other product. The gene as a functional unit consists of a discrete segment of a giant DNA molecule containing the purine (adenine and guanine) and pyrimidine (cytosine and thymine) bases in the ordered and correct sequence that encodes a specific functional product (i.e., a protein or RNA molecule).","longName":"C16612","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB05-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7507227","version":"1","preferredName":"Gene Mutation Name","preferredDefinition":"The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.:The words or language units by which a thing is known.","longName":"C18093:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gene Mutation","conceptCode":"C18093","definition":"The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4648A18-3D3B-5E66-E053-4EBD850A0245","latestVersionIndicator":"Yes","beginDate":"2020-11-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-18","modifiedBy":"ONEDATA","dateModified":"2020-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4648A18-3D4C-5E66-E053-4EBD850A0245","latestVersionIndicator":"Yes","beginDate":"2020-11-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-18","modifiedBy":"COOPERM","dateModified":"2020-11-18","changeDescription":"Created for NCI-INC0538595 20C0161 Exon and codon request. 11.17.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Other Gene Mutation","type":"Preferred Question Text","description":"Other Gene Mutation","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4653A6A-E97E-6086-E053-4EBD850A0A0B","latestVersionIndicator":"Yes","beginDate":"2020-11-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-18","modifiedBy":"COOPERM","dateModified":"2020-11-18","changeDescription":"Created for NCI-INC0538595 20C0161 Exon and codon request. 11.17.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}